DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: LEMTRADA (Campath, alemtuzumab)
       *****************************************************
       #Post#: 2517--------------------------------------------------
       EMA to restrict use of alemtuzumab pending review
       By: agate Date: May 14, 2019, 8:34 pm
       ---------------------------------------------------------
       The concern about stroke risk has prompted the European
       Medicines Agency to restrict the use of alemtuzumab pending
       review. From The Lancet (April 27, 2019), "Alemtuzumab to be
       restricted pending review, says EMA":
  HTML https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)30935-3/fulltext
       *****************************************************